Orange Book product · Generic (ANDA)
AMPHETAMINE SULFATE
AMPHETAMINE SULFATE
At a glance
Nov 22, 2019
Approved
Generic (ANDA)
Application
AA
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 22, 2019
6 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
AMPHETAMINE SULFATE
Strength
5MG
Dosage form
TABLET
Route
ORAL
TE code
AA
Application
ANDA 212919
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of AMPHETAMINE SULFATE
- 2021EVEKEO ODTBrand (NDA)
NDA 209905 · AZURITY
- 2021AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 213852 · RHODES PHARMS
- 2021AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 212186 · GLENMARK PHARMS LTD
- 2021AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 214574 · SUN PHARM INDS INC
- 2021AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 213583 · SPECGX LLC
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 213720 · ALKEM LABS LTD
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 213980 · EPIC PHARMA LLC
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 213763 · INGENUS PHARMS LLC
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 213898 · DR REDDYS LABS SA
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 212901 · SENORES PHARMS
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 211861 · PRINSTON INC
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 212582 · SANALUZ
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

